Compare ZLAB & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | AXGN |
|---|---|---|
| Founded | 2013 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2017 | 2013 |
| Metric | ZLAB | AXGN |
|---|---|---|
| Price | $22.66 | $48.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 11 |
| Target Price | $33.48 | ★ $59.09 |
| AVG Volume (30 Days) | 955.0K | ★ 1.8M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $460,156,000.00 | $225,208,000.00 |
| Revenue This Year | N/A | $28.93 |
| Revenue Next Year | $26.74 | $28.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 15.33 | ★ 20.21 |
| 52 Week Low | $15.96 | $23.00 |
| 52 Week High | $27.50 | $52.91 |
| Indicator | ZLAB | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 45.61 | 75.68 |
| Support Level | $21.86 | $38.75 |
| Resistance Level | $26.64 | $52.91 |
| Average True Range (ATR) | 1.14 | 1.97 |
| MACD | -0.12 | 1.83 |
| Stochastic Oscillator | 33.86 | 91.87 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.